For patients, the promise of effective weight loss coupled with health improvements is appealing
Consult your provider about which format suits your clinical needs and budget
We are regulated by the General Pharmaceutical Council (GPhC), registered with the National Pharmaceutical Association (NPA), MHRA approved, PCI DSS compliant, ICO registered, and hold LegitScript certification
Clinical studies show patients often regain a significant portion of lost weight within several months of discontinuation, making lifestyle modifications and ongoing support important
daily) Other health conditions that could affect your safety or suitability for treatment Cost and insurance coverage, which can vary greatly between drugs While semaglutide and tirzepatide generally show the highest average weight loss in trials, liraglutide may still be the better choice for certain patients